Literature DB >> 9646118

Chronic myelogenous leukemia in an HIV-infected patient.

X de la Tribonniere, R Leberre, I Plantier, S Alfandari, C Beuscart, J P Jouet, Y Mouton.   

Abstract

Entities:  

Mesh：

Year:  1998        PMID： 9646118     DOI： 10.1007/bf02771855

Source DB:  PubMed          Journal:  Infection        ISSN： 0300-8126            Impact factor:   3.553


× No keyword cloud information.
  5 in total

1.  Chronic myeloid leukemia in a homosexual HIV-seropositive man.

Authors:  I Lorand-Metze; S L Morais; C A Souza
Journal:  AIDS       Date:  1990-09       Impact factor: 4.177

2.  Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluation.

Authors:  M Giacca; S Zanussi; M Comar; C Simonelli; E Vaccher; P de Paoli; U Tirelli
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection.

Authors:  J Vila; F Biron; F Nugier; T Vallet; D Peyramond
Journal:  Lancet       Date:  1996-07-20       Impact factor: 79.321

4.  Hydroxyurea treatment in HIV-infected patients.

Authors:  C Simonelli; G Nasti; E Vaccher; U Tirelli; S Zanussi; P De Paoli; M Comar; M Giacca
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-12-15

Review 5.  Heterogeneity of acute lymphoblastic leukemia in HIV-seropositive patients.

Authors:  L Gérinière; Y Bastion; C Dumontet; G Salles; D Espinouse; B Coiffier
Journal:  Ann Oncol       Date:  1994-05       Impact factor: 32.976
  5 in total
  2 in total

1.  Chronic myeloid leukaemia and human immunodeficiency virus (HIV) infection.

Authors:  Michael J Webb; Claire L Barrett; Christel Pretorius; Magdalena F van Jaarsveld; Vernon J Louw
Journal:  Int J Hematol       Date:  2012-04-20       Impact factor: 2.319

2.  Provirus reactivation is impaired in HIV-1 infected individuals on treatment with dasatinib and antiretroviral therapy.

Authors:  Lorena Vigón; Paula Martínez-Román; Sara Rodríguez-Mora; Montserrat Torres; María C Puertas; Elena Mateos; María Salgado; Antonio Navarro; Matilde Sánchez-Conde; Juan Ambrosioni; Miguel Cervero; Christoph Wyen; Christian Hoffmann; José M Miró; José Alcamí; Daniel Podzamczer; Valentín García-Gutiérrez; Javier Martínez-Picado; Verónica Briz; María Rosa López-Huertas; Vicente Planelles; Mayte Coiras
Journal:  Biochem Pharmacol       Date:  2021-06-26       Impact factor: 6.100
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.